Abstract
Scleroderma can be differentiated into progressive systemic and circumscript forms. The extensive form with lethal outcome is known from case reports of children and adolescents. The present case report concerns a boy who died at 16 years of age. In the 5th year of life, he experienced weight loss and developed multiple, firm, partially atrophic plaques in the skin of the extremities. These plaques gradually became confluent and extended over the whole torso and head. Plaque ulceration resulted in massive mutilations to the body. Later the patient's cachexia worsened and he developed keratose, moderately differentiated squamous cell carcinoma of the right leg. The prognosis of pansclerotic morphea for children is worse than for adults. No successful therapy is known.
Similar content being viewed by others
References
Ozkan S, Atebey N, Fetil E, Erkizan V, Gunes AT (2000) Evidence for borrelia burgdorferi in morphea and lichen sclerosus. Int J Dermatol 39:278–283
De Vito JR, Merogi AJ, Vo T Boh EE, Fung HK, Freeman SM, Cockerell C, Stewart K, Marrogi AJ (1996) Role of borrelia burgdorferi in the pathogenesis of morphea/scleroderma and lichen sclerosus et atrophicus : a PCR study of 35 cases. J Cutan Pathol 23:350–358
Diaz-Perez JL, Connolly SM, Winkelmann RK (1980) Disabling pansclerotic morphea in children. Arch Dermatol 116:169–173
Gruss C, Stücker M, von Kobyletzki G, Schreiber D, Altmeyer P, Kerscher M (1997) Low dose UVA1 phototherapy in disabling pansclerotic morphea of childhood. Br J Dermatol 136:293–294
Stücker M, Schreiber D, Gruss C, Freitag M, von Kobyletzki G, Kerscher M, Altmeyer P (1999) Schwerer Verlauf einer mutilierenden pansklerotischen zirkumskripten Sklerodermie im Kindesalter. Hautarzt 50:131–135
Todd DJ, Askari A, Ektaish E (1998) PUVA therapy for disabling pansclerotic morphea in childhood. Br J Dermatol 138:2081–2082
Ferrandiz C, Henkes J, Gonzalez J, Peyri J (1981) Incapacitating pansclerotic morphea in childhood. Med Cutan Ibero Lat Am 9:377–382
Wollina U, Looks A, Uhlemann C, Wollina K (1999) Panclerotic morphea of childhood—follow-up over 6 years. Pediatr Dermatol 16:245–247
Parodi PC, Riberti C, Draganic Stinco D, Patrone P, Stinco G (2001) Squamous cell carcinoma arising in a patient with long-standing pansclerotic morphea. Br J Dermatol 144:417–419
Scharfetter-Kochanek K, Goldermann R, Lehmann P (1995) PUVA-therapy in disabling pansclerotic morphea of children. Br J Dermatol 132:830–831
Kerscher M, Dirschka T, Volkenadt M (1995) Treatment of localized scleroderma by UVA 1 phototherapy. Lancet 346:1166
Kerscher M, Volkenandt M, Meurer M, Lehmann P, Plewig G, Rocken M (1994) Treatment of localized scleroderma by PUVA bath photochemotheraoy. Lancet 343:1233
Wollina U, Looks A, Schneider R, Maak B (1998) Disabling morphoea of childhood—beneficial effect of intravenous immunoglobulin therapy. Clin Exp Dermatol 23:292–293
Wollina U, Karte K, Herold C, Looks A (2000) Biosurgery in wound healing—the renaissance of maggot therapy. J Eur Acad Dermatol Venereol 14:285–289
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Doede, T., Wollina, U., Hindermann, W. et al. Pansclerotic morphea in childhood: a case report. Ped Surgery Int 19, 406–408 (2003). https://doi.org/10.1007/s00383-003-1020-7
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00383-003-1020-7